Immunic (IMUX) Current Assets (2013 - 2026)

Immunic has disclosed Current Assets across 14 years of filings, most recently posting $188.8 million for Q1 2026.

• Current Assets for Q1 2026 came in at $188.8 million, up 894.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $188.8 million (up 894.78% YoY), and the FY2025 annual result was $22.9 million, down 41.86% from the prior year.
• Current Assets came in at $188.8 million for Q1 2026 at Immunic, up from $22.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $188.8 million in Q1 2026 to a low of $19.0 million in Q1 2025.
• The 5-year median for Current Assets is $85.0 million (2024), against an average of $80.2 million.
• Across the five-year window, Current Assets sank 81.51% in 2025 and jumped 894.78% in 2026, its largest moves.
• Immunic's Current Assets stood at $125.9 million in 2022, then tumbled by 58.26% to $52.5 million in 2023, then fell by 25.13% to $39.3 million in 2024, then sank by 41.86% to $22.9 million in 2025, then jumped by 725.39% to $188.8 million in 2026.
• The last three Current Assets figures came in at $188.8 million (Q1 2026), $22.9 million (Q4 2025), and $39.3 million (Q3 2025), per Business Quant data.